![]() | Monter d'un niveau |
Astolfi, M., Péant, B., Lateef, M. A., Rousset, N., Kendall-Dupont, J., Carmona, E., Monet, F., Saad, F., Provencher, D., Mes-Masson, A. M., & Gervais, T. (2016). Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Lab on a Chip, 16(2), 312-325. Lien externe
Astolfi, M., St-Georges-Robillard, A., Leblond, F., Mes-Masson, A.-M., & Gervais, T. (2016). Microfluidics and spectroscopic imaging for personalized medicine in ovarian cancer. SPIE Newsroom. Lien externe
Choi, B., Kollias, N., Zeng, H., Kang, H. W., Wong, B. J. F., Ilgner, J. F., Tearney, G. J., Gregory, K. W., Marcu, L., Skala, M. C., Campagnola, P. J., Mandelis, A., Morris, M. D., St-Georges-Robillard, A., Masse, M., Kendall-Dupont, J., Strupler, M., Patra, B., Jermyn, M., ... Gervais, T. (février 2016). Spectroscopic imaging system for high-throughput viability assessment of ovarian spheroids or microdissected tumor tissues (MDTs) in a microfluidic chip [Communication écrite]. Photonic Therapeutics and Diagnostics XII, San Francisco, California. Lien externe
Gokce, O., Castonguay, S., Temiz, Y., Gervais, T., & Delamarche, E. (octobre 2016). Passive "orthogonal flow mixers" for homogeneous dissolution of reagents in microfluidics [Communication écrite]. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2016), Dublin, Ireland. Non disponible
Lateef, M. A., Péant, B., Carmona, E., Rousset, N., Simeone, K., Kendall-Dupont, J., Orimoto, A. M., Mes-Masson, A.-M., Gervais, T., & Saad, F. (juin 2016). The use of a microfluidic chip platform for the ex vivo rapid measurement of chemotherapeutic responses in 3D sub millimeter biopsy samples . Dans American Society of Clinical Oncology (ASCO) Annual Meeting I, Chicago, Illinois. Publié dans Journal of Clinical Oncology, 34(15_suppl). Lien externe
Lateef, M. A., Péant, B., Rousset, N., Simeone, K., Kendall-Dupont, J., Mari Orimoto, A., Mes-Masson, A.-M., Gervais, T., & Saad, F. (juin 2016). Rapid prediction of personalized response to chemotherapy using sub-millimeter ex-vivo biopsy samples on chip [Affiche]. Congrès annuel de l'Association des urologues du Canada (CUA 2016), Vancouver, B.-C.. Lien externe
Patra, B., Brunet, A. R., Zerouali, K., Carrier, J. F., Wong, P., & Gervais, T. (octobre 2016). On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids [Communication écrite]. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2016), Dublin, Ireland. Non disponible
Patra, B., Carmona, E., Lateef, M. A., Kendall-Dupont, J., Peant, B., Provencher, D., Mes-Masson, A. M., & Gervais, T. (octobre 2016). Are 3D spheroids always more resistant to chemotherapy than 2D cultures? A chip-based survey using ovarian cancer cell lines [Communication écrite]. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2016), Dublin, Ireland. Non disponible